Dennis Merkle

Company: NeoGenomics Laboratories

Job title: Senior Vice President, Pharma Services

Seminars:

NeoGenomics: Navigating the Ever-Changing Biomarker & CDx Landscapes to Ensure Stakeholder Alignment & Wide-Spread Accessibility 5:50 pm

• Tumor informed MRD can support clinical development in a number of ways (e.g. patient enrichment, monitoring, surveillance) • While many MRD applications for solid tumors continue to emerge, CDx development with these technologies will also be required in the near future • NeoGenomics is uniquely positioned with the RaDaR technology to support all MRD…Read more

day: Day 1 PM